
Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey
Author(s) -
Robert A. Domaoal,
Katrina Sleeman,
Souleymane Sawadogo,
Tafadzwa Dzinamarira,
Ndahafa Frans,
Saara P Shatumbu,
Ligame Kakoma,
Terthu K Shuumbwa,
Mackenzie Hurlston Cox,
Sally C. Stephens,
Lydia Nisbet,
Melissa Metz,
Suzue Saito,
Daniel B. Williams,
Andrew C. Voetsch,
Hetal Patel,
Bharat Parekh,
Yen T. Duong
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002706
Subject(s) - genexpert mtb/rif , medicine , concordance , human immunodeficiency virus (hiv) , population , point of care , external quality assessment , quality assurance , turnaround time , tuberculosis , emergency medicine , virology , environmental health , sputum , pathology , computer science , operating system
In the population-based HIV impact assessment surveys, early infant diagnosis (EID) was provided to infants <18 months without a prior diagnosis. For the Namibia population-based HIV impact assessment (NAMPHIA), the GeneXpert platform was assessed for the feasibility of near POC EID testing compared with the standard Roche COBAS AmpliPrep/COBAS TaqMan (CAP/CTM) platform. Quality assurance measures and turnaround time were compared to improve EID results reporting.